Viewing Study NCT01232894


Ignite Creation Date: 2025-12-25 @ 1:43 AM
Ignite Modification Date: 2026-02-02 @ 11:53 PM
Study NCT ID: NCT01232894
Status: COMPLETED
Last Update Posted: 2013-11-19
First Post: 2010-11-01
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: 12-week Open-label Evaluation of Efficacy and Safety of Indacaterol
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Obstructive Pulmonary Disease (COPD) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None indacaterol View
None COPD View
None Long-acting beta2-agonist (LABA) View